Deerfield Beach, FL -- (SBWIRE) -- 12/12/2016 -- The nuclear medicine market is expected to exceed more than US$ 4.5 billion by 2021 growing at around 9.0% CAGR for the given forecast period.

Browse Full Report: https://www.marketresearchengine.com/reportdetails/nuclear-medicine-market

Nuclear medicine is special category in medical branch used for diagnosis and treatment of disease in a safe and painless way. Nuclear medicine contain radioactive material which combined called as radiopharmaceutical. The small quantity of radiopharmaceutical is given into human body in the form of injection or swallowing. It goes to specific location of a body where there could be disease or abnormality. It emits radiation called gamma rays and contains gamma camera which helps nuclear medicine physician to see inside the body. It takes pictures of inner body which helps physician to diagnose patients' disease.

The important factors driving the nuclear medicine market are advances in radiotracers and alpha radio immunotherapy-based targeted cancer treatment. SPECT and PET scans usage has been increasing to detect diseases like cancer which is driving the nuclear medicine market. Raising the incidence of cancer and cardiac ailments are also responsible for growing the nuclear medicine market. The nuclear medicine market is also having some restraints such as strict regulatory and global Good Manufacturing Practice guidelines. One of the major restraint is that most of the hospital still rely on conventional diagnostic procedures and not able to shift to nuclear medicine due to cost and availability issues. (Radiopharmaceuticals Market) The life of radiopharmaceuticals is small so that sometimes the use of this is restricted.

Download Free Sample Report: https://www.marketresearchengine.com/requestsample/nuclear-medicine-market

This report provides:

1) An overview of the global market for nuclear medicine and related technologies.

2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2021.

3) Identifications of new market opportunities and targeted promotional plans for nuclear medicine.

4) Discussion of research and development, and the demand for new products and new applications.

5) Comprehensive company profiles of major players in the industry.

REPORT SCOPE:

The scope of the report includes a detailed study of global and regional markets for various types of nuclear medicine with the reasons given for variations in the growth of the industry in certain regions.

The Top Companies Report is intended to provide our buyers with a snapshot of the industry's most influential players.

The Nuclear Medicine Market has been segmented as below:

By Procedural Volume Segment Analysis

Diagnostics

SPECT Radiopharmaceuticals
PET Radiopharmaceuticals
Therapeutics
Beta Emitters
Alpha Emitters
Brachytherapy Isotopes

By Type Analysis

Diagnostics
SPECT Radiopharmaceuticals
Tc-99
Tl-201
Ga-67
I-123
PET Radiopharmaceuticals
F-18
Ru-82
Others

Therapeutics

Beta Emitters
I-131
Sm-153
Rh-186
Y-90
Lu-177
Others
Alpha Emitters
Ra-223
Brachytherapy Isotopes
I-125
Ir-192
Pa-103
Cs-131
Others

By Application Analysis

- Diagnostics
- SPECT
- Cardiology
- Lymphoma
- Thyroid
- Neurology
- Others
- PET
- Oncology
- Cardiology
- Neurology
- Others
- Therapeutics
- Thyroid
- Bone Metastasis
- Lymphoma
- Endocrine Tumors
- Others

By Regional Analysis

- North America
- Europe
- Asia-Pacific
- Rest of the World

About Market Research Engine
Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.